How long does it take for an SSRI to work?

The short answer

How long does it take an SSRI to work? For most adults with major depression, a selective serotonin reuptake inhibitor reaches its full antidepressant effect at 4 to 6 weeks on a therapeutic dose. That's the well-established research finding, replicated across hundreds of clinical trials.

"Full effect at 4–6 weeks" doesn't mean nothing happens for four weeks. Most patients notice something within the first two weeks — usually sleep, anxiety, or appetite improvement before the mood shift itself becomes clear. The deeper improvement consolidates over weeks four through six. If you're six weeks in on a therapeutic dose and feel nothing, it's time to talk to your prescriber about a change.

A realistic week-by-week timeline

Week 1

Usually the hardest week. Side effects tend to peak in days 3–7 — nausea, mild GI upset, headaches, slightly altered sleep, sometimes increased anxiety. There's typically no antidepressant benefit yet. The goal of week 1 is to take the medication consistently and ride out the initial side effects.

Week 2

Side effects usually start to fade by mid-week. Some patients begin to notice early benefits: anxiety feels slightly more manageable, sleep is a bit more reliable. Mood itself usually hasn't shifted noticeably yet.

Weeks 3–4

This is when the most noticeable shift typically happens. Mood starts to feel measurably better. Things that seemed pointless start to seem slightly more worth doing. PHQ-9 scores at week 4 are usually meaningfully lower than at baseline if the medication is working.

Weeks 4–6

Consolidation. The improvements from weeks 2–4 deepen and become more reliable. By week 6 on an adequate dose, you should have a reasonably clear answer to whether this medication is helping you. Around 60% of patients respond well to their first SSRI; 40% need a dose increase, a switch, or augmentation.

What "working" actually looks like

SSRIs don't make you feel happy. They don't blunt your emotions (with rare exceptions). They don't replace therapy or solve life problems. What they do, when they work, is restore a baseline that depression has compressed:

• Things you used to enjoy feel slightly more accessible
• Sleep, appetite, and energy stabilize
• Negative thoughts get quieter — not absent
• Anxiety, often, decreases alongside

What working doesn't look like: euphoria, dramatic personality changes, or immediate symptom disappearance.

Early side effects, and which are normal

• GI upset — nausea, loose stools. Usually peaks days 3–5, resolves by week 2. Taking with food helps.
• Headache — mild, often peaks days 2–4.
• Sleep changes — initially harder to sleep, or vivid dreams. Often improves by week 2.
• Initial anxiety increase — some patients feel briefly more anxious in the first week.
• Sexual side effects — these can appear at any point and often persist. Worth discussing openly; there are mitigations.

When to call your prescriber

• New or worsening suicidal thoughts — especially in younger adults during the first 4 weeks
• Severe agitation, restlessness, or akathisia
• Rash, especially on the trunk
• Any genuinely intolerable side effect
• Symptoms suggesting a manic switch — sustained sleeplessness with euphoric energy, racing thoughts, impulsive decisions

If you're in crisis at any point, call or text 988, call 911, or go to your nearest emergency room.

If it isn't working at week 4 or 6

About 40% of patients don't respond adequately to their first SSRI at the initial dose. That's a known clinical reality, not a personal failure. Standard next steps include a dose increase (many patients respond at a higher dose), a switch to a different SSRI or SNRI, augmentation with a second medication, or — for treatment-resistant cases — broader options like TMS, esketamine, or specialty referrals.

If you're taking it for an anxiety disorder

SSRIs are first-line treatment for generalized anxiety disorder, panic disorder, social anxiety disorder, and OCD as well as for depression. The timeline is broadly similar, with two practical differences worth knowing.

First, people with an anxiety disorder are noticeably more sensitive to the activating effect of the first week — the jitteriness, the racing heart, the sense that the medication is making things worse. This is why anxious patients are started at half the usual dose, or lower, and titrated slowly. It is a dosing problem, not a sign the medication is wrong.

Second, the full anxiety response often takes longer than the depression response — frequently 8 to 12 weeks, and often at a higher final dose. OCD in particular typically requires doses at the top of the licensed range and a 10-to-12-week trial before the medication can be called a failure.

For where medication sits alongside everything else, see the GAD-7 anxiety test.

Weighing the risks and benefits

The honest version, because the decision is a trade-off rather than an obvious yes:

• The benefit is meaningful and well documented in moderate-to-severe depression. Roughly 60% of patients respond to their first SSRI, and combined with therapy the numbers are better still. In mild depression the advantage over placebo is smaller, which is why therapy and lifestyle changes are usually tried first.
• The common costs are early GI upset and headache, which fade, and sexual side effects, which often do not and are frequently the reason people stop. Worth naming up front rather than discovering later.
• The uncommon but serious risks include a manic switch in people with undiagnosed bipolar disorder, serotonin syndrome when combined with other serotonergic drugs, hyponatremia in older adults, and increased bleeding risk alongside NSAIDs or anticoagulants.
• Other health conditions shape the choice. Cardiac history, liver function, seizure disorder, pregnancy and lactation, and your other medications all narrow or widen the list of reasonable options.

None of this argues against treatment. It argues for a prescriber who reviews your full medication list, asks about family psychiatric history, and follows up in weeks rather than months.

Stopping: discontinuation syndrome

SSRIs are not habit-forming in the addiction sense, but the body does adapt to them, and stopping abruptly commonly produces discontinuation syndrome: dizziness, flu-like aching, nausea, irritability, vivid dreams, and the electrical "brain zap" sensation that is oddly specific to this class. Symptoms usually begin two to four days after the last dose.

It is unpleasant rather than dangerous, and it is largely avoidable. Two things determine the risk: half-life and taper speed. Paroxetine and venlafaxine have short half-lives and cause the most trouble; fluoxetine has a long half-life and effectively tapers itself. A standard taper runs over two to four weeks, longer after years of treatment or at higher doses.

Discontinuation symptoms are also frequently mistaken for relapse. The distinguishing features are timing and character — discontinuation starts within days and involves physical symptoms, while relapse builds over weeks and looks like the original depression returning. Plan any stop with your prescriber rather than tapering alone.

Frequently asked questions